RXO

RXO Inc.
NYSEINDUSTRIALSTRUCKING

Key Statistics

Market Cap
$4.55B
P/E Ratio
—
EPS
$-0.52
Beta
1.85
52W High
$29.90
52W Low
$10.43
50-Day MA
$24.25
200-Day MA
$21.31
Dividend Yield
—
Profit Margin
-1.35%
Forward P/E
2500.00
PEG Ratio
172.13

About RXO Inc.

RXO Inc. is a leading entity in the transportation and logistics sector, specializing in advanced freight solutions across North America. Leveraging innovative technology and data analytics, RXO significantly improves supply chain efficiency and cost-effectiveness for a diverse clientele. The company's unwavering focus on sustainability and continuous innovation enhances its operational prowess and competitive stature in a dynamic logistics landscape. With a robust network and strategic alliances, RXO is strategically positioned to meet the evolving needs of the industry, representing a promising opportunity for institutional investors looking for growth in logistics.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$6.54B
Gross Profit (TTM)$947.00M
EBITDA$116.00M
Operating Margin1.28%
Return on Equity-5.69%
Return on Assets0.15%
Revenue/Share (TTM)$38.63
Book Value$9.19
Price-to-Book3.03
Price-to-Sales (TTM)0.70
EV/Revenue0.811
EV/EBITDA123.28
Quarterly Earnings Growth (YoY)-93.20%
Quarterly Revenue Growth (YoY)31.70%
Shares Outstanding$164.95M
Float$135.37M
% Insiders0.76%
% Institutions111.23%

Historical Volatility

HV 10-Day
32.32%
HV 20-Day
24.44%
HV 30-Day
68.49%
HV 60-Day
57.58%
HV Rank
52.8%

Volatility is currently contracting

Analyst Ratings

Consensus ($29.83 target)
1
Strong Buy
2
Buy
15
Hold

Latest News

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR)

BALA CYNWYD, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

GlobeNewsWire10/30/2026Neutral
RXO (RXO) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for RXO (RXO) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research10/29/2026Positive
RXO (RXO) Q3 Earnings and Revenues Top Estimates

RXO (RXO) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.01 per share a year ago.

Zacks Investment Research10/29/2026Positive
Despite Fast-paced Momentum, RXO (RXO) Is Still a Bargain Stock

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, RXO (RXO) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks Investment Research10/22/2026Positive
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG)

BALA CYNWYD, Pa., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

GlobeNewsWire10/20/2026Neutral
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of RXO, Inc. (NYSE: RXO)

NEW YORK, Oct. 6, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating RXO, Inc. (NYSE: RXO) related to its sale to C.H.

PRNewsWire10/6/2026Neutral
RXO (RXO) Is Attractively Priced Despite Fast-paced Momentum

RXO (RXO) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks Investment Research10/6/2026Positive
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR), WaFd, Inc. (Nasdaq – WAFD)

BALA CYNWYD, Pa., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

GlobeNewsWire10/5/2026Neutral
RXO Stock Alert: Halper Sadeh LLC is Investigating Whether RXO Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of RXO Inc. (NYSE: RXO) to C.H. Robinson Worldwide, Inc. for $17.25 per share in cash and 0.0856 shares of C.H. Robinson common stock for each RXO share. Upon closing of the Proposed Transaction, RXO shareholders are expected to own 11% of the combined company. Halper Sadeh encourages RXO shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Ha.

Business Wire10/5/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on RXO and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More INDUSTRIALS Stocks

Data last updated: 11/7/2026